Navigation Links
Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army
Date:11/18/2008

ategy in Iraq and Afghanistan and biometrics is a high interest area for the Department of Defense. We are honored to play a part in the development of capabilities to meet current and future warfighter requirements."

About Stanley

Stanley (NYSE: SXE) is a provider of information technology services and solutions to U.S. defense and federal civilian government agencies. Stanley offers its customers systems integration solutions and expertise to support their mission-essential needs at any stage of program, product development or business lifecycle through five service areas: systems engineering, enterprise integration, operational logistics, business process outsourcing, and advanced engineering and technology. Headquartered in Arlington, Va., the company has more than 4,700 employees at over 100 locations in the U.S. and worldwide. In 2008 and 2007, Stanley was recognized by FORTUNE(R) magazine as one of the "100 Best Companies to Work For." Please visit http://www.stanleyassociates.com for more information.

Any statements in this press release about our future expectations, plans and prospects, including statements containing the words "estimates," "anticipates," "plans," "expects" and similar expressions, constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors discussed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2008, our Quarterly Report on Form 10-Q for the fiscal quarters ended June 27, 2008, and September 26, 2008, as filed with the Securities and Exchange Commission (SEC), and additional filings we make with the SEC. In addition,
'/>"/>

SOURCE Stanley, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Stanley to Acquire Oberon Associates
2. Stanley to Acquire Oberon Associates
3. DFG continues to strengthen biodiversity research
4. Researchers continue to find genes for type 1 diabetes
5. Study shows continued spread of dead zones
6. Anything but modest: The mouse continues to contribute to humankind
7. 55th anniversary of Nobel honoring double helix continues to overlook the late Rosalind Franklin
8. e-SMART Technologies Continues Delivery of Its New Super SMART Card in South Korea
9. Scientific evidence supporting evolution continues to grow
10. Dakotas continue to yield paleontological treasures
11. Entrust Continues Leadership by Adding Support for Next-generation E-Passports

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ose is pleased to announce the publication of resu... the efficacy and tolerability of its novel, intra...t of chronic rhinosinusitis with nasal polyps in ...nal and European Rhinologic Societies. , Chroni...sease that can significantly reduce a patient,s qu...
(Date:12/1/2009)...ble in German . , Brown adipose tissue is dif...mitochondria, miniature power stations which among...normally generate a voltage similar to that of a b...ocesses. However, the mitochondria of brown fat ce... all the time. The energy released when the fat is...
(Date:12/1/2009)...r of the 2009 Inserm Grand Prix., Every year sin...ing tribute to outstanding,work performed in its ..., Inserm intends to,demonstrate the diversity and...al, medical and,health research, and the creativi...and,drive this research each day. The Inserm 2009...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 1MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 2MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 3America Speaks Out in Favor of Affordable Healthcare and Biogenerics in Tevas Fourth Video 49901 1America Speaks Out in Favor of Affordable Healthcare and Biogenerics in Tevas Fourth Video 49901 2Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 1Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 2Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 3
...ay to direct chemical modifications to specific si...nal antibodies so important in the pharmaceutical ...nd her colleagues at the U.S. Department of Energy...niversity of California at Berkeley. , Many thera...an be made in bacterial systems like Escherichia ...
...s in the small Georgian town of Reepham in Norfolk...ial, led by the University of East Anglia (UEA). ...d, the properties depend on heating oil for warmth... prove that environmentally-friendly renewable hea... being used is sustainable biodiesel manufactured ...
...) Based on a striking similarity between heart di... at Columbia University Medical Center have discov...art failure may also help treat the fatal muscular...he muscle-wasting Duchenne disease couldn,t appear...fore the age of 6, destroying their muscle cells. ...
Other Biology News:Tailor-made recombinant proteins in mammals 2Tailor-made recombinant proteins in mammals 3Tailor-made recombinant proteins in mammals 4Trailblazing rural community shows green heating oil a viable option 2While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy 2
(Date:12/2/2009)...a, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceuti...R ), a leading pharmaceutical company,specializing...of branded,generic and proprietary pharmaceuticals...ave been included in China,s National Drug Reimbur...Ministry of Human Resources and Social,Security on...
(Date:12/2/2009)... 2 According to the National Insti...ans diagnosed with diabetes already have some stag...damage to the retina caused by leaky blood vessels...betes and is one of the most feared diabetic compl...ts who,ve had diabetes for 10 years or more will e...
(Date:12/1/2009)... 1 Reportlinker.com announces that...catalogue: ,, Industrial Enzymes - A Global Ma...164431/Industrial-Enzymes---A-Global-Market-Report...poly with few strong players and a host of small s...competition and commoditization characterize the i...
(Date:12/1/2009)... Leader Richard Gephardt Brings Together A-List fr...ties for "Best and Brightest Forum on Medical Inn...wire-USNewswire/ -- Several of New Jersey,s most p...medicine and technology gathered today at the Libe...dical innovation in New Jersey, and throughout the...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5
... Accera, Inc., a biotechnology company delivering...(CNS) diseases, today launched Axona(TM) in the Un... a first-in-class medical food for the clinical di...ated with mild-to-moderate Alzheimer,s. Dispensed ...cies and imbalances associated with AD by providin...
...re-FirstCall/ - Angiotech Pharmaceuticals, Inc. (N...btained a new Senior Secured Term Loan and Revolvi...he sole arranger, administrative agent and lender ...ty. , The financing includes a delayed draw secure...ecured revolving credit facility with a borrowing ...
...h 2 Bionovo, Inc.,(Nasdaq: BNVI ) today announc...le in the journal, Menopause, reporting Menerba(TM...ective for the treatment of vasomotor symptoms,(ho...use. , The Phase 2 clinical trial was designed...of Menerba versus placebo. The trial was conducted...
Other Biology Technology:Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 2Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 3Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 4Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 2Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 4Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM) 2Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM) 3Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM) 4
...dary Detection System uses biotin-avidin-HRP compl...rimary Antibody. The primary antibody binds to spe... antibody is removed by washing. Next, the Seconda...d and will react with the primary antibody present...
... a wide range of hands-on techniques that are usef...reas of protein chemistry and molecular biology., ...st how valuable this book will be to your research...background of a method or group of related methods...
...ed RNA (dsRNA) has been shown to induce RNA interf...insect cells in culture. RNA interference leads to... sequence-specific, dsRNA-mediated destruction of ...e RNA interference using long dsRNA in mammalian c...
...counts, similar to an infrared beam break system, ... in two frames of reference, recording can be trig...nd allow social interaction as part of the activit...avior situations, including output based on the an...
Biology Products: